id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-320920-mceoozy8	Ali, Zain	Acute COVID-19 Induced Fulminant Systemic Vascular Thrombosis: A Novel Entity	2020-08-14		.txt	text/plain	1147	82	32	[1] [2] [3] Here, we invoke a new variant of coagulopathy, acute COVID-19 induced fulminant systemic vascular thrombosis (ACoFSVT) characterized by a rapid, widespread, massive peripheral arteriovenous coagulopathy. [4] In our case, irrespective of the endothelial injury, the collision of COVID-19 induced direct vascular thrombosis, inherent to the disease-specific hypercoagulable state, and possible vasculopathy, due to long-standing diabetes triggered vascular occlusion. The rise in d-dimer levels tracked with inflammatory biomarkers (CRP), reflecting both coagulopathy and vascular inflammation, a cause for acute COVID-19 related fulminant systemic vascular thrombosis (ACoFSVT). Regardless, it is imperative to identify early clinical risk factors such as baseline medical conditions that predispose to vasculopathy, significant elevated inflammatory markers and in particular high levels of d-dimer, and adopt an individualized approach to initiation of early therapeutic anticoagulation in these patients. While remarkable efforts to unravel further management of acute COVID-19 related thrombotic complications are ongoing, we advocate for early recognition and timely anticoagulation in patients with high-risk features suggestive of ACoFSVT.	./cache/cord-320920-mceoozy8.txt	./txt/cord-320920-mceoozy8.txt